pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·1h ago·1 min read
save

Companies price the role, not the employee, says executive coach on compensation expectations

Oct 21, 2026·read at BioSpace ↗Negative

Executive coach Angela Justice argues that firms usually set pay based on the value of the job itself rather than the individual who fills it. She says this distinction is often clear in theory but harder to accept when a salary figure directly affects a person.

She recounts a recruiter presenting a salary range that was $20,000 lower than her current base, prompting an immediate feeling that the company did not recognize her worth. Justice clarifies that the employer was communicating what the role costs them, not a judgment of her personal value.

Justice notes that higher performance, more experience, or greater contribution do not automatically translate into higher pay. Understanding that compensation is a function of job scope and market scarcity can help workers make more informed career choices.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Opinion: Your company isn’t paying you what you’re worth”

read at BioSpace ↗
1,057 words · retrieved 14m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • just now2026 IPO stock tracker: How newly public biotechs are performingBioSpace
  • 1h agoThe 6 biggest crossover rounds in biopharma historyBioSpace
  • 1h agoChina’s licensing deals soar as US biotechs enjoy a bumper M&A yearBioSpace
  • 15h agoRapport ekes out bipolar mania win as lead asset ‘just hits’ in mid-stage trialBioSpace
  • 16h agoEyepoint, Enlivex enact heavy layoffsBioSpace